EVI1-ChIP in two EVI1high AML cell lines, OCI-AML-4 and OCI-AML-6, demonstrated enrichment of binding at the predicted EVI1 site at +1379bp on the INPP4B promoter (Fig 4F and 4G). This evidence concerns the gene INPP4B and acute myeloid leukemia.